Chunwang Yuan

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang et al. · Signal Transduction and Targeted Therapy · 2023 · 283 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu et al. · EClinicalMedicine · 2024 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram

Chunwang Yuan, Zhenchang Wang, Dongsheng Gu et al. · Cancer Imaging · 2019 · 91 citations · Full text

Medicine, Oncology, Radiology +17

Colorimetric Immunosensor Based on Au@g-C₃N₄-Doped Spongelike 3D Network Cellulose Hydrogels for Detecting α-Fetoprotein

Fang Ma, Chunwang Yuan, Jian‐Ni Liu et al. · ACS Applied Materials & Interfaces · 2019 · 49 citations

Life Sciences, Biomedical Engineering, Biotechnology +17

Overexpression of apoptosis-inducing factor mitochondrion-associated 1 (AIFM1) induces apoptosis by promoting the transcription of caspase3 and DRAM in hepatoma cells

Dongjie� Liu, Mingyang Liu, Wenjing Wang et al. · Biochemical and Biophysical Research Communications · 2018 · 44 citations

Life Sciences, Cell Biology, Molecular Biology +9